Objectif
Epilepsy is a major burden for patients and health systems worldwide. It is a common chronic neurological disorder affecting people of all ages, and the shortfall in existing treatments means that 30% of patients continue to suffer uncontrolled seizures. MicroRNAs (miRNA) are a recently-discovered, network-level layer of gene expression regulation that controls protein levels of entire signaling pathways. Research on miRNAs has unprecedented potential to (i) further our understanding of the underlying disease processes, (ii) deliver novel signatures and prognostic markers for response to therapy, and (iii) deliver novel therapeutics and drug targets. EpiMiRNA consortium members have pioneered discoveries on brain-specific miRNAs, established that miRNA changes are a feature of the pathophysiology of human temporal lobe epilepsy and have demonstrated experimentally that altering miRNA function can potently suppress epileptic seizures and seizure-damage. EpiMiRNA brings together experts on the neurobiology of miRNAs with the leading researchers working on miRNAs in epilepsy, epilepsy geneticists, leaders in miRNA-target detection, proteomics, and systems biology with research-intensive SMEs pursuing miRNA therapeutics and treatments for pharmacoresistant epilepsy. Through highly collaborative, inter-disciplinary and inter-sectorial research, EpiMiRNA will explain the mechanism by which miRNAs contribute to epileptogenesis, characterize genetic variation of miRNA in patients, evaluate seizure-suppressing effects of miRNAs in experimental models, identify novel miRNA modulatory molecules as potential future therapeutics, and develop miRNAs as prognostic markers to identify patients who respond to novel, non-pharmacological therapeutic interventions including brain stimulation. EpiMiRNA will generate the necessary critical mass in biomedical, clinical and industry/SME research to track, treat and prevent seizures and improve the clinical management of epilepsy patients.
Champ scientifique
Appel à propositions
FP7-HEALTH-2013-INNOVATION-1
Voir d’autres projets de cet appel
Régime de financement
CP-IP - Large-scale integrating projectCoordinateur
2 Dublin
Irlande
Voir sur la carte
Participants (18)
35037 Marburg
Voir sur la carte
3584 CX Utrecht
Voir sur la carte
WC1E 6BT LONDON
Voir sur la carte
37129 Verona
Voir sur la carte
91054 Erlangen
Voir sur la carte
Participation terminée
27708 Durham Nc
Voir sur la carte
13083 875 Campinas Sp
Voir sur la carte
8000 Aarhus C
Voir sur la carte
5230 Odense M
Voir sur la carte
Participation terminée
25025 BESANCON
Voir sur la carte
91052 ERLANGEN
Voir sur la carte
6534 AB Nijmegen
Voir sur la carte
81241 MUENCHEN
Voir sur la carte
02130 Espoo
Voir sur la carte
Participation terminée
80333 Muenchen
Voir sur la carte
10027 7003 New York
Voir sur la carte
75008 Paris
Voir sur la carte
25640 CHAUDEFONTAINE
Voir sur la carte